Abstract Details

Title Psychometric evaluation of quality of life measures in a three-arm, randomized, double-blind, placebo-controlled phase III study of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who have refractory partial-onset seizures (EXIST-3)

Topic ��ɫ��, Research, and Methodology

Presentation(s) P2 - (-)

Poster/Presentation
Number 057

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
David N. Franz, MD (CCHMC/MLC 2015)	No disclosure on file
Paolo Curatolo (Hotelplan)	No disclosure on file
	No disclosure on file
Noah Berkowitz	No disclosure on file
Maureen Neary	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Antonio V. Salgado, MD (Hospital Fernando Fonseca)	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��